Back
MoonLake Immunotherapeutics 10K Form
Sell
46
MLTX
MoonLake Immunotherapeutics
Last Price:
$14.89
Seasonality Move:
19.6%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MLTX News And Ratings
See the #1 stock for the next 7 days that we like better than MLTX
MLTX Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-44.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.54 |
| Price / Book: | 3.65 |
Profitability
| EPS (TTM): | -3.32780 |
|---|---|
| Net Income (TTM): | $-213.7M |
| Gross Margin: | $-1.4M |
| Return on Equity: | -53.14% |
| Return on Assets: | -44.86% |
MoonLake Immunotherapeutics Earnings Forecast
Key MoonLake Immunotherapeutics Financial Ratios
-
Per Share Earnings over the last 5 years have been positive in 2 years.
MoonLake Immunotherapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MLTX |
| Website: | moonlaketx.com |
Debt
| Debt-to-Equity Ratio: | 0.26 |
|---|---|
| Current Ratio: | 8.5 |
| Quick Ratio: | 7.87 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MLTX Technical Analysis vs Fundamental Analysis
Sell
46
MoonLake Immunotherapeutics (MLTX)
is a Sell
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a SellThe current MoonLake Immunotherapeutics [MLTX] share price is $14.90. The Score for MLTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.